Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pilates boosts lung function in overweight women, study finds

NCT ID NCT07103499

Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 15, 2026 · Updated 2 times

Summary

This study looked at whether an 8-week Pilates exercise program could improve breathing in overweight and obese women. 54 women were split into an exercise group and a control group. The exercises focused on core strength and abdominal endurance. Researchers measured lung function, breath-holding time, and quality of life before and after the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Jun 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

inclusion criteria 1. Women aged 18-60 2. Body mass index (BMI) ≥ 25 kg/m² (obese and overweight) 3. Baseline FEV0 value ≥ 80% (measured by spirometry) 4. Individuals without respiratory disease (no diagnosis of asthma, COPD, etc.) 5. Individuals who have not engaged in regular exercise in the past 6 months 6. Individuals without orthopedic or neurological conditions that physically prevent participation in the exercise protocol 7. Non-pregnant individuals 8. Individuals who voluntarily agree to participate in the study and sign the informed consent form exclusion criteria 1\. Individuals with a FEV0 value \<80% (due to risk of obstructive lung disease) 2. Individuals who have undergone surgery in the abdomen, waist, or pelvic area within the last 6 months 3. Individuals with orthopedic, neurological, or systemic diseases that would prevent them from exercising 4. Individuals who have been engaging in regular exercise for 3 or more days per week in the past 3 months 5. Individuals with diagnosed respiratory diseases (e.g., asthma, COPD, etc.) 6. Individuals who are unable to comply with the exercise program due to psychiatric diagnosis or communication difficulties

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Muscle weakness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung disorder Muscle Weakness Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Muscle weakness Obesity Overweight Pulmonary disease

Contacts and locations

Locations

  • Fizyoterapist Reyhan Arzum Apraş Özel Sağlık Meslek Hizmet Birimi

    Çorum, Merkez, 19200, Turkey (Türkiye)

  • Ondokuz Mayıs Üniversitesi

    Samsun, Atakum, 55270, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.